Role of fever in infection: Has induced fever any therapeutic potential in HIV infection?

Genitourinary Medicine

Volumn 73, Issue 3, 1997, Pages 212-215

  Morton, R S ^a   Rashid, Sakina ^a  

^a SUNDERLAND ROYAL HOSPITAL   (United Kingdom)

Author keywords

Fever; History; HIV AIDS

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; FEVER; HISTORY OF MEDICINE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; REVIEW;

EID: 0030792342     PISSN: 02664348     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.73.3.212     Document Type: Review

References (20)

1. Chadwick J, Manor WN. The medical works of Hippocrates (translation). Book 1. Epidemics. Oxford: Blackwell Scientific Publications, 1950:204-35.
2. Major RH. A history of medicine. Springfield, IL: CC Thomas, 1954:174-88.
3. Wood WB. Studies on the cause of fever. N Engl J Med 1958;258:1023-31.
4. Wagner von Jauregg J. Ueber die Einwirking febuhafter Enkrankungen auf Psychosen. Jahrbuch fur Psychiatrie 1887;7:94-134.
5. Wagner von Jauregg J. Ueber die Einwirking der Malaria auf die progressive Paralyse. Psychiat-neural Wschr 1918-19;20:132-4, 251-5.
6. Jezova D, Kvetnansky R, Vigas M. Sex differences in endocrine response to hyperthermia in sauna. Acta Physiol Scand 1994;150:293-8.
7. Stokes JH, Beerman H, Ingraham NR. Modern clinical syphilology. Philadelphia: WB Saunders, 1945; 157, 351.
8. Editorial. British Journal of Venereal Disease 1956;32:1.
9. Lowff A. Factors influencing the evolution of viral diseases of the cellular level and in the organism. Bacteriol Rev 1959;23:104-24.
10. Thompson RL, Coates MS. The effect of temperature upon the growth and survival of myxoma, herpes and vaccinia viruses in tissue cultures. J Infect Dis 1942;71: 83-5.
11. Nowak T, Niedrig M, Bernhardt D, Hilfenhaus J. Inactivation of HIV, HBV, HCV related viruses and other viruses in human plasma derivatives, by pasteurisation (Review). Dev Biol Stand 1993;81:169-76.
12. Orloff SL, Wallingford JC, McDougal JS. Inactivation of human immunodeficiency virus type 1 in human milk: effects of intrinsic factors in human milk and of pasteurisation. J Hum Lact 1993;9:13-7.
13. Tjotta E. Survival of HIV-1 activity after disinfection, temperature and pH changes or drying. J Med Virol 1991;35:223-7.
14. Van Bueren J. Survival of HIV and inactivation by heat and chemical disinfectants. Amsterdam: Eighth International Conference on AIDS, 1992.
15. Alonso K, Pontiggia P, Sabato A, Calvi G, Curto FC, de Bartolomei E, et al. Systemic hyperthermia in the treatment of HIV related, disseminated Kaposi's sarcoma. Long term follow up of patients treated with low-flow extracorporeal perfusion hyperthermia. Am J Clin Oncol 1994;17:353-9.
16. Steinhart CR, Ash SR, Gingrich C, Sapir D, Keeling GN, Yalvin MB. Effect of whole body hyperthermia on AIDS patients with Kaposi's sarcoma: a pilot study. Journal of AIDS and Human Retrovirology 1996;11:271-81.
17. Morita M, Suzuki T, Nakajima K, Shiozawa C, Gill MJ, Hoshino H. Characteristics and clinical significance of a stabilisation assay to detect specific antibodies to reverse transcriptase of HIV. Clin Diagn Lab Immunol 1995;2: 583-9.
18. Pennypacker C, Perelson AS, Nys N, Nelson G, Sessler DI. Localised or systemic in vivo heat inactivation of human immunodeficiency virus (HIV): a mathematical analysis. Journal of AIDS and Human Retrovirology 1995; 8:321-9.
19. Pakianathan MR. Antiretroviral therapy; a review. Proc Roy Coll Phys Edinb 1996;26:261-4.
20. Levy JA. HIV research; a need to focus on the right target. Lancet 1995;345:1619-21.